Immediate Impact
3 from Science/Nature 52 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Works of Graeme Young being referenced
Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumours
2014
Disposition and Metabolism of GSK2251052 in Humans: A Novel Boron-Containing Antibiotic
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Graeme Young | 201 | 73 | 77 | 143 | 124 | 37 | 634 | |
| Douglas Ferguson | 179 | 36 | 92 | 126 | 139 | 25 | 594 | |
| Frank W. Lee | 173 | 77 | 24 | 215 | 181 | 21 | 686 | |
| Masaki Ishigai | 250 | 47 | 16 | 119 | 127 | 52 | 732 | |
| Oliver Scherf‐Clavel | 162 | 32 | 39 | 49 | 140 | 60 | 717 | |
| J J Lima | 158 | 77 | 229 | 86 | 80 | 35 | 689 | |
| Richard L. Lalonde | 105 | 157 | 38 | 162 | 75 | 32 | 685 | |
| Jackie C. Bloomer | 258 | 50 | 37 | 264 | 178 | 20 | 739 | |
| Haiyung Cheng | 107 | 60 | 177 | 142 | 104 | 40 | 711 | |
| Madelé van Dyk | 179 | 52 | 48 | 136 | 192 | 35 | 656 | |
| Sarah Shugarts | 128 | 115 | 22 | 133 | 254 | 13 | 675 |
All Works
Login with ORCID to disown or claim papers
Loading papers...